Correlation Between NextTrip and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NextTrip and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextTrip and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextTrip and Spyre Therapeutics, you can compare the effects of market volatilities on NextTrip and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextTrip with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextTrip and Spyre Therapeutics.

Diversification Opportunities for NextTrip and Spyre Therapeutics

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NextTrip and Spyre is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding NextTrip and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and NextTrip is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextTrip are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of NextTrip i.e., NextTrip and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between NextTrip and Spyre Therapeutics

Given the investment horizon of 90 days NextTrip is expected to generate 3.85 times more return on investment than Spyre Therapeutics. However, NextTrip is 3.85 times more volatile than Spyre Therapeutics. It trades about 0.29 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.19 per unit of risk. If you would invest  185.00  in NextTrip on September 2, 2024 and sell it today you would earn a total of  197.00  from holding NextTrip or generate 106.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NextTrip  vs.  Spyre Therapeutics

 Performance 
       Timeline  
NextTrip 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NextTrip are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, NextTrip reported solid returns over the last few months and may actually be approaching a breakup point.
Spyre Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

NextTrip and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NextTrip and Spyre Therapeutics

The main advantage of trading using opposite NextTrip and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextTrip position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind NextTrip and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies